Scolr to co-develop its CDT drug delivery technology

By Lisa Kerner

Charlotte, N.C., Sept. 14 - Scolr Pharma, Inc. said it formed a research agreement with an unnamed global consumer products company to co-develop a novel application of its CDT drug delivery technology in exchange for a research fee.

"This agreement allows us to potentially capitalize on a new application of our CDT technology and may provide our partner with increased product differentiation," senior vice president of business and legal affairs Alan M. Mitchel said in a company news release.

This is the Bellevue, Wash.-based specialty pharmaceutical company's third collaboration in the last 10 months.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.